Literature DB >> 20393721

[Female patient with Muir-Torre syndrome].

N Negraszus1, K Jöhrens, E Bertelmann.   

Abstract

Muir-Torre syndrome is a rare form of genodermatosis characterized by sebaceous tumours or keratocanthoma and early occurrence of intestinal malignancies. In addition to the patient history immunohistochemical and genetic analysis for microsatellite instability and reduced expression of the mismatch repair gene MSH2 and MLH1 can be used to confirm the diagnosis. Because of this important association, Muir-Torre syndrome should be excluded if a patient presents with a sebaceous tumour.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20393721     DOI: 10.1007/s00347-010-2165-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  10 in total

1.  Inflammatory nodules around the axilla: an uncommon localization of orf virus infection.

Authors:  B Weide; G Metzler; T K Eigentler; B Fehrenbacher; K Sönnichsen; C Garbe
Journal:  Clin Exp Dermatol       Date:  2008-12-22       Impact factor: 3.470

2.  Hereditary nonpolyposis colorectal cancer (HNPCC): eight novel germline mutations in hMSH2 or hMLH1 genes.

Authors:  M Wehner; L Buschhausen; C Lamberti; R Kruse; R Caspari; P Propping; W Friedl
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

3.  Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.

Authors:  Giovanni Ponti; Lorena Losi; Carmela Di Gregorio; Luca Roncucci; Monica Pedroni; Alessandra Scarselli; Piero Benatti; Stefania Seidenari; Giovanni Pellacani; Luigi Lembo; Giuseppina Rossi; Massimiliano Marino; Emanuela Lucci-Cordisco; Maurizio Ponz de Leon
Journal:  Cancer       Date:  2005-03-01       Impact factor: 6.860

4.  Muir-Torre syndrome: Diagnostic and screening guidelines.

Authors:  Brad Jones; Carol Oh; Elisabeth Mangold; Conleth A Egan
Journal:  Australas J Dermatol       Date:  2006-11       Impact factor: 2.875

Review 5.  Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome.

Authors:  P R Cohen; S R Kohn; R Kurzrock
Journal:  Am J Med       Date:  1991-05       Impact factor: 4.965

6.  Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations.

Authors:  R D Kolodner; N R Hall; J Lipford; M F Kane; M R Rao; P Morrison; L Wirth; P J Finan; J Burn; P Chapman
Journal:  Genomics       Date:  1994-12       Impact factor: 5.736

Review 7.  The Muir-Torre syndrome: a 25-year retrospect.

Authors:  R A Schwartz; D P Torre
Journal:  J Am Acad Dermatol       Date:  1995-07       Impact factor: 11.527

8.  Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria.

Authors:  R Kruse; A Rütten; C Lamberti; H R Hosseiny-Malayeri; Y Wang; C Ruelfs; M Jungck; M Mathiak; T Ruzicka; W Hartschuh; M Bisceglia; W Friedl; P Propping
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

9.  Identifying Muir-Torre syndrome in a patient with glioblastoma multiforme.

Authors:  Deric M Park; Gabrielle A Yeaney; Ronald L Hamilton; Jennifer Mabold; Nikki Urban; Leonard Appleman; John Flickinger; Frank Lieberman; Arlan Mintz
Journal:  Neuro Oncol       Date:  2008-11-21       Impact factor: 12.300

10.  The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre's syndrome.

Authors:  H T Lynch; P M Lynch; J Pester; R M Fusaro
Journal:  Arch Intern Med       Date:  1981-04
  10 in total
  1 in total

1.  [Sebaceous gland tumor with a rare gene mutation within a tumor syndrome: Muir-Torre syndrome].

Authors:  E Voigt; F Sommer; K D Geiger; L E Pillunat
Journal:  Ophthalmologe       Date:  2014-04       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.